Skip to main content
Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
63.32
+1.08 (1.74%)
Feb 27, 2026, 4:00 PM EST - Market closed

Haemonetics Revenue

Haemonetics had revenue of $338.97M in the quarter ending December 27, 2025, a decrease of -2.75%. This brings the company's revenue in the last twelve months to $1.32B, down -4.02% year-over-year. In the fiscal year ending March 29, 2025, Haemonetics had annual revenue of $1.36B with 3.95% growth.

Revenue (ttm)
$1.32B
Revenue Growth
-4.02%
P/S Ratio
2.23
Revenue / Employee
$436,082
Employees
3,023
Market Cap
2.94B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 29, 20251.36B51.77M3.95%
Mar 30, 20241.31B140.40M12.01%
Apr 1, 20231.17B175.46M17.67%
Apr 2, 2022993.20M122.73M14.10%
Apr 3, 2021870.46M-118.02M-11.94%
Mar 28, 2020 Pro Pro Pro
Mar 30, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Apr 1, 2017 Pro Pro Pro
Apr 2, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Integer Holdings 1.85B
LivaNova 1.39B
Tandem Diabetes Care 1.01B
Inspire Medical Systems 911.98M
Alphatec Holdings 764.16M
iRhythm Holdings 747.14M
TransMedics Group 605.49M
UFP Technologies 602.80M
Revenue Rankings

HAE News

More News